| Mechanisms of key innate immune cells in early-and late-onset preeclampsia I Aneman, D Pienaar, S Suvakov, TP Simic, VD Garovic, L McClements Frontiers in immunology 11, 1864, 2020 | 148 | 2020 |
| 3D Bioprinted cancer models: Revolutionizing personalized cancer therapy R Augustine, SN Kalva, R Ahmad, AA Zahid, S Hasan, A Nayeem, ... Translational Oncology 14 (4), 101015, 2021 | 124 | 2021 |
| Risk of pre‐eclampsia in women taking metformin: a systematic review and meta‐analysis A Alqudah, MC McKinley, R McNally, U Graham, CJ Watson, TJ Lyons, ... Diabetic Medicine 35 (2), 160-172, 2018 | 104 | 2018 |
| Top notch targeting strategies in cancer: a detailed overview of recent insights and current perspectives G Moore, S Annett, L McClements, T Robson Cells 9 (6), 1503, 2020 | 103 | 2020 |
| Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway L McClements, A Yakkundi, A Papaspyropoulos, H Harrison, MP Ablett, ... Clinical cancer research 19 (14), 3881-3893, 2013 | 72 | 2013 |
| RALA-mediated delivery of FKBPL nucleic acid therapeutics R Bennett, A Yakkundi, HD McKeen, L McClements, TJ McKeogh, ... Nanomedicine 10 (19), 2989-3001, 2015 | 62 | 2015 |
| Can stem cells beat COVID-19: advancing stem cells and extracellular vesicles toward mainstream medicine for lung injuries associated with SARS-CoV-2 infections W Chrzanowski, SY Kim, L McClements Frontiers in Bioengineering and Biotechnology 8, 555476, 2020 | 60 | 2020 |
| FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4 L McClements, S Annett, A Yakkundi, M O’Rourke, A Valentine, ... BMC cancer 19, 1-14, 2019 | 54 | 2019 |
| Elucidating the pathogenesis of pre-eclampsia using in vitro models of spiral uterine artery remodelling R McNally, A Alqudah, D Obradovic, L McClements Current hypertension reports 19, 1-13, 2017 | 54 | 2017 |
| Stem cell-based approaches in cardiac tissue engineering: controlling the microenvironment for autologous cells R Augustine, P Dan, A Hasan, IM Khalaf, P Prasad, K Ghosal, C Gentile, ... Biomedicine & Pharmacotherapy 138, 111425, 2021 | 50 | 2021 |
| FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer S Annett, G Moore, A Short, A Marshall, C McCrudden, A Yakkundi, S Das, ... British Journal of Cancer 122 (3), 361-371, 2020 | 44 | 2020 |
| Identification of RBCK1 as a novel regulator of FKBPL: implications for tumor growth and response to tamoxifen C Donley, K McClelland, HD McKeen, L Nelson, A Yakkundi, PV Jithesh, ... Oncogene 33 (26), 3441-3450, 2014 | 42 | 2014 |
| Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation R Augustine, S Abhilash, A Nayeem, SA Salam, P Augustine, P Dan, ... Chemico-biological interactions 351, 109738, 2022 | 41 | 2022 |
| Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial repair N Fergie, N Todd, L McClements, D McAuley, C O’Kane, ... The FASEB Journal 33 (4), 5585, 2019 | 38 | 2019 |
| Association of Nrf2, SOD2 and GPX1 Polymorphisms with Biomarkers of Oxidative Distress and Survival in End-Stage Renal Disease Patients D Jerotic, M Matic, S Suvakov, K Vucicevic, T Damjanovic, ... Toxins 11 (7), 431, 2019 | 37 | 2019 |
| FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis A Yakkundi, R Bennett, I Hernández-Negrete, JM Delalande, M Hanna, ... Arteriosclerosis, thrombosis, and vascular biology 35 (4), 845-854, 2015 | 37 | 2015 |
| Extracellular vesicles from mesenchymal stromal cells for the treatment of inflammation-related conditions ST Ryan, E Hosseini-Beheshti, D Afrose, X Ding, B Xia, GE Grau, CB Little, ... International Journal of Molecular Sciences 22 (6), 3023, 2021 | 35 | 2021 |
| Emerging therapeutic potential of mesenchymal stem/stromal cells in preeclampsia S Suvakov, C Richards, V Nikolic, T Simic, K McGrath, ... Current hypertension reports 22, 1-13, 2020 | 35 | 2020 |
| Plasma amino acids metabolomics' important in glucose management in type 2 diabetes A Alqudah, M Wedyan, E Qnais, H Jawarneh, L McClements Frontiers in pharmacology 12, 695418, 2021 | 33 | 2021 |
| The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway A Yakkundi, L McCallum, A O’Kane, H Dyer, J Worthington, HD McKeen, ... PloS one 8 (2), e55075, 2013 | 33 | 2013 |
